(Q39435553)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Poli Mara Spritzer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

I Velho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

T M Fighera

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

P K Ziegelmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

14 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

881-888

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Testosterone decreases adiponectin levels in female to male transsexuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Alterations in Lipids and Adipocyte Hormones in Female-to-Male Transsexuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Effects of cross-sex hormone treatment on transgender women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Increased arterial stiffness in female-to-male transsexuals treated with androgen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Hormone treatment of the adult transsexual patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Efficacy and safety of testosterone replacement therapy in men with hypogonadism: A meta-analysis study of placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Endocrine intervention for transsexuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

A psycho-endocrinological overview of transsexualism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Effects of three different testosterone formulations in female-to-male transsexual persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Androgens and erythropoiesis: past and present

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Safety of physiological testosterone therapy in women: lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Mortality and morbidity in transsexual subjects treated with cross-sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Long-term evaluation of cross-sex hormone treatment in transsexual persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANDR.12382

21 January 2018

Identifiers

DOI

10.1111/ANDR.12382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28709177%20AND%20SRC:MED&resulttype=core&format=json

release_qrjtv2g5pngqjbfz27d7kf2kbm

25 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qrjtv2g5pngqjbfz27d7kf2kbm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference